Cytokinetics CEO Robert I. Blum disposes of $490,950 in common shares
CYTK•Cytokinetics CEO Robert I. Blum exercised options for 7,500 shares at $10.60 and sold 7,500 shares at $65.46 on Sept. 28, 2026, leaving him with 278,544 directly held shares.
1. Share transactions
Blum exercised stock options for 7,500 shares at $10.60 and sold the same number of shares at $65.46 on Sept. 28, 2026. He directly held 278,544 common shares following the transactions.
